Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

ALSUntangled found no independently verifiable evidence that GM604 is effective or safe

Original source

GM604ALSUntangled · 4 April 2016

An ALSUntangled review found no independently verifiable data supporting the effectiveness or safety of GM604 in people with ALS. It called for the preliminary data to be released for independent peer review and replication before GM604 is considered effective or safe.

Why this matters

This means the review does not support using GM604 as an established treatment for ALS. It also judged expanded access premature because independently verifiable safety data were not available.

Limitations and context

This is an independent expert review, not a new clinical trial or independently verified primary research. The review described the available data as preliminary and said larger, longer studies would be needed if positive results were confirmed. The conclusion is based on the information available in this single review.

Relevant to you?